The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines
- 15 September 2010
- Vol. 28 (46) , 7436-7443
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Comparison of Clinical Application of the Abbott HBV PCR Kit and the Versant HBV DNA 3.0 Test to Measure Serum Hepatitis B Virus DNA in Taiwanese PatientsThe Kaohsiung Journal of Medical Sciences, 2009
- Engineering immune therapy against hepatitis B virusHepatology Research, 2007
- DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent mannerVirology, 2006
- Pegylated Interferons for the Treatment of Chronic Hepatitis BRecent Patents on Anti-Infective Drug Discovery, 2006
- Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic Hepatitis B virus infectionAntiviral Research, 2004
- Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis BHepatology, 2004
- Clinical Trial Results and Treatment Resistance with Lamivudine in Hepatitis BSeminars in Liver Disease, 2004
- Entecavir Therapy Combined with DNA Vaccination for Persistent Duck Hepatitis B Virus InfectionAntimicrobial Agents and Chemotherapy, 2003
- Hepatitis B infection: Pathogenesis and managementJournal of Hepatology, 2000
- Characterization of Age- and Dose-Related Outcomes of Duck Hepatitis B Virus InfectionVirology, 1998